SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (108)12/6/1996 2:39:00 PM
From: Henry Niman   of 6136
 
margie, Here's what I posted on Dec 4 under Ligand thread ;-)
To: Lenny Ehn (119 )
From: Henry Niman
Dec 4 1996 5:11PM EST
Reply #123 of 148

Len, When MM wrote his article in late October, AGPH was well on the way
to a double of its secondary price in less than 3 months (from $30 to
$60). In November it did pull back and now is closing in on 60 again.
When it was 30, AGPH and LGND had similar market caps. Now AGPH is
about double LGND. I think MM felt that much of AGPH's potential
was already reflected in its price while LGND still had much of its
potential in the form of hopes and dreams. I tend to agree with this view.
My background is Biochemistry, not finance, which you should keep
in mind when reading my evaluation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News